Federica Lorenzi

513 total citations
8 papers, 372 citations indexed

About

Federica Lorenzi is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Federica Lorenzi has authored 8 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in Federica Lorenzi's work include Neuroblastoma Research and Treatments (3 papers), Cell death mechanisms and regulation (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Federica Lorenzi is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Cell death mechanisms and regulation (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Federica Lorenzi collaborates with scholars based in United Kingdom, Netherlands and United States. Federica Lorenzi's co-authors include Abdolrahman S. Nateri, Mehreen Ahmed, Sameerah Shaheen, Roya Babaei‐Jadidi, Bradley Spencer‐Dene, Ningning Li, Ian Tomlinson, Enric Domingo, Eugene Tulchinsky and Robert G.J. Vries and has published in prestigious journals such as Cancer Letters, Oncotarget and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Federica Lorenzi

7 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Lorenzi United Kingdom 6 230 192 104 48 35 8 372
Cristina Zahonero Spain 6 174 0.8× 66 0.3× 55 0.5× 29 0.6× 23 0.7× 7 318
Andressa Gois Morales Brazil 11 250 1.1× 70 0.4× 133 1.3× 28 0.6× 79 2.3× 13 353
Lynn M. Opdenaker United States 10 190 0.8× 166 0.9× 69 0.7× 9 0.2× 25 0.7× 20 342
Komal Qureshi-Baig Luxembourg 7 260 1.1× 152 0.8× 225 2.2× 9 0.2× 27 0.8× 7 430
Giorgia Foggetti Italy 11 235 1.0× 183 1.0× 103 1.0× 19 0.4× 9 0.3× 18 365
Linda Schild Netherlands 10 283 1.2× 122 0.6× 111 1.1× 203 4.2× 29 0.8× 17 397
Harriet Southgate United Kingdom 4 230 1.0× 131 0.7× 41 0.4× 37 0.8× 22 0.6× 4 288
Sri HariKrishna Vellanki Ireland 9 274 1.2× 101 0.5× 64 0.6× 13 0.3× 27 0.8× 13 340
Anna Maria Bello Italy 8 317 1.4× 104 0.5× 235 2.3× 11 0.2× 22 0.6× 14 436
Katarzyna Chmielarska Masoumi Sweden 11 316 1.4× 145 0.8× 97 0.9× 13 0.3× 59 1.7× 16 415

Countries citing papers authored by Federica Lorenzi

Since Specialization
Citations

This map shows the geographic impact of Federica Lorenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Lorenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Lorenzi more than expected).

Fields of papers citing papers by Federica Lorenzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Lorenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Lorenzi. The network helps show where Federica Lorenzi may publish in the future.

Co-authorship network of co-authors of Federica Lorenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Lorenzi. A scholar is included among the top collaborators of Federica Lorenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Lorenzi. Federica Lorenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lorenzi, Federica, Sina Jostes, Qiong Gao, et al.. (2025). ATRX mutations mediate an immunogenic phenotype and macrophage infiltration in neuroblastoma. Cancer Letters. 613. 217495–217495. 1 indexed citations
2.
George, Sally L., Federica Lorenzi, David S. King, et al.. (2020). Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma. EBioMedicine. 59. 102971–102971. 47 indexed citations
3.
George, Sally L., Virinder S. Parmar, Federica Lorenzi, et al.. (2020). Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. Journal of Experimental & Clinical Cancer Research. 39(1). 78–78. 37 indexed citations
4.
Li, Ningning, Roya Babaei‐Jadidi, Federica Lorenzi, et al.. (2019). An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance. Oncogenesis. 8(3). 13–13. 115 indexed citations
5.
Shaheen, Sameerah, Mehreen Ahmed, Federica Lorenzi, & Abdolrahman S. Nateri. (2016). Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer. Stem Cell Reviews and Reports. 12(4). 492–499. 108 indexed citations
6.
Lorenzi, Federica, Roya Babaei‐Jadidi, Jonathan Sheard, Bradley Spencer‐Dene, & Abdolrahman S. Nateri. (2016). Fbxw7-associated drug resistance is reversed by induction of terminal differentiation in murine intestinal organoid culture. Molecular Therapy — Methods & Clinical Development. 3. 16024–16024. 29 indexed citations
7.
Li, Ningning, Federica Lorenzi, Eliana Kalakouti, et al.. (2015). FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15. Oncotarget. 6(11). 9240–9256. 35 indexed citations
8.
Lorenzi, Federica, et al.. (2015). Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal cabergoline treatment. Reproductive Toxicology. 57. 218–218.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026